The Company was in compliance with all covenants as of June 28, 2019.
In September 2018, the Company terminated its existing interest rate swaps.
On February 20, 2019, the Company's Civil segment disposed of its commercial cybersecurity business in order to focus on providing solutions, including cybersecurity, to the Company's core markets of governments and highly regulated industries.
The term of the lease is expected to end during fiscal 2036.
The majority of the Company's revenues are generated from U.S. government contracts, either as a prime contractor or as a subcontractor to other contractors.
During the quarter ended March 30, 2018, an impairment charge of $7 million associated with this property was recorded within Corporate.
Amortization expense was $43 million and $86 million, for the quarter and six months ended June 28, 2019, respectively, and $51 million and $101 million for the quarter and six months ended June 29, 2018, respectively.
In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02 ("ASC 842"), which supersedes the current lease guidance under Leases (Topic 840) and makes several changes, such as requiring an entity to recognize a right-of-use ("ROU") asset and corresponding lease obligation on the balance sheet, classified as financing or operating, as appropriate.
On February 21, 2019, the Company entered into an Accelerated Share Repurchase ("ASR") agreement with a financial institution to repurchase shares of its outstanding common stock.
Effective the beginning of fiscal 2019, certain contracts were reassigned between the Civil and Defense Solutions reportable segments (see "Note 18â€“Business Segments").
As of June 28, 2019, and December 28, 2018, there were no borrowings outstanding under the credit facility.
The interest rate swap agreements on $300 million and $250 million of the Company's Variable Rate Loans both had a maturity date of August 2022 and fixed interest rates of 1.66% and 2.59%, respectively.On February 16, 2018, our Board of Directors authorized a new share repurchase program of up to 20 million shares of our outstanding common stock.
All were funded at increased levels from the previous year.
The increase in revenues for the three and six months ended June 28, 2019, as compared to the three and six months ended June 29, 2018, was primarily attributable to a net increase in program volumes and new awards, partially offset by the completion of certain contracts.
Unless indicated otherwise, references in this report to the "Company," "we," "us" and "our" refer collectively to Leidos and its consolidated subsidiaries.None.